(Press-News.org) The angiotensin-converting enzyme (ACE) inhibitor drug, ramipril, is particularly effective in lowering the risk of end-stage renal disease (ESRD) in obese patients, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
"Obese patients with kidney disease progress more quickly towards renal failure compared to non-obese patients, and ramipril virtually abolishes this excess risk," comments Carmine Zoccali, MD (CNR-IBIM and Ospedali Riuniti di Reggio Calabria, Italy).
The researchers analyzed data from a previous trial comparing ramipril with an inactive placebo in 337 patients with non-diabetes-related chronic kidney disease (CKD). Rates of progression to ESRD on the two treatments were compared in obese and overweight patients versus normal-weight patients.
On placebo, the risk of developing ESRD was more than twice as high for obese patients compared to normal-weight patients: 24 versus 10 per 100 person-years. For patients who were overweight but not obese, ESRD risk was similar to that in normal-weight patients.
Ramipril lowered the risk of progression to ESRD in all three weight groups. However, the magnitude of risk reduction was much greater for obese patients: 86 percent, compared to 45 percent in normal-weight patients. Thus, obese patients taking ramipril exhibited about the same ESRD risk as normal-weight patients.
"Obesity is now the most frequent cause of CKD," according to Zoccali. "In the United States, one out of four patients starting dialysis is obese." Ramipril and other ACE inhibitors are frequently used to treat CKD in patients with high levels of protein in the urine (proteinuria), like the ones in the study.
"Our findings strongly suggest that ACE inhibitors should be preferentially used in obese patients to prevent kidney disease moving to the most advanced stages," Zoccali concludes. He calls for further analyses to confirm the results, as well as new trials specific to obese patients with CKD.
As a new analysis of a previous clinical trial, the study cannot be considered as definitive proof that ACE inhibitors have any special impact in obese patients with CKD. In addition, the study focused on kidney disease associated with high levels of proteinuria; it's unknown whether ACE inhibitors will have the same protective effect in patients with lower levels of proteinuria. Furthermore, the patients were all white Europeans; the results need to be confirmed in studies including other ethnicities.
###
The authors reported no financial disclosures.
Study co-authors were Francesca Mallamaci, MD, Piero Ruggenenti, MD, Annalisa Perna, Stat SciD, Daniela Leonardis MD, Rocco Tripepi, Giovanni Tripepi, Stat SciD, and
Giuseppe Remuzzi, MD. Drs. Ruggenenti, Perna, and Remuzzi are at Mario Negri Institute for Pharmacological Research, Bergamo, Italy. Drs. Remuzzi and Ruggenenti were the leaders of the Ramipril Efficacy in Nephropathy (REIN) study, the primary source of data for the new study.
The article, entitled "ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria" will appear online at http://jasn.asnjournals.org/ on April 28, 2011, doi 10.1681/ASN.2010090969.
The American Society of Nephrology (ASN) does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 12,000 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
Reducing risk of renal failure in obese patients
2011-04-29
ELSE PRESS RELEASES FROM THIS DATE:
Scientists detect early warning signal for ecosystem collapse
2011-04-29
MADISON — Researchers eavesdropping on complex signals emanating from a remote Wisconsin lake have detected what they say is an unmistakable warning — a death knell — of the impending collapse of the lake's aquatic ecosystem.
The finding, reported today (April 29) in the journal Science by a team of researchers led by Stephen Carpenter, a limnologist at the University of Wisconsin-Madison, is the first experimental evidence that radical change in an ecosystem can be detected in advance, possibly in time to prevent ecological catastrophe.
"For a long time, ecologists ...
Being tall, obese may significantly increase risk of blood clots in deep veins
2011-04-29
Being tall and obese may increase your risk for potentially dangerous blood clots, according to new research in Arteriosclerosis, Thrombosis and Vascular Biology: Journal of the American Heart Association.
Obesity is a well-known risk factor for clots in deep veins (usually in the legs) and for pulmonary embolism, a clot in blood vessels of the lungs that can result in sudden death or strain on the heart. Together, the two conditions are called venous thromboembolism (VTE).
Compared with short (5 feet, 7.7 inches or less) and normal-weight men (body mass index < 25kg/m2), ...
Mystery solved: How sickle hemoglobin protects against malaria
2011-04-29
The latest issue of the journal Cell* carries an article that is likely to help solve one of the long-standing mysteries of biomedicine. In a study that challenges currently held views, researchers at the Instituto Gulbenkian de Ciência (IGC), in Portugal, unravel the molecular mechanism whereby sickle cell hemoglobin confers a survival advantage against malaria, the disease caused by Plasmodium infection. These findings, by the research team lead by Miguel P. Soares, open the way to new therapeutic interventions against malaria, a disease that continues to inflict tremendous ...
Wordpress Training for the UK -- Aperio Training Now Provides the UK's Best Wordpress Training
2011-04-29
For the past seven years Aperio Training and Education systems has been providing quality accredited SEO training and Wordpress Training for over 3,500 students across the USA and Canada. Now with their even popular advanced Wordpress training now offered through their live 100% online class room portal is being offered to the UK.
If you've ever wanted to master wordpress, Aperio's training guarantees they can help you master Wordpress in a mere few hours, NOT DAYS! Discover what this powerful Wordpress Training can do for you and your business. Find out how to perform ...
Finding molecular targets of an HIV drug used in cancer therapy
2011-04-29
Researchers at the University of California, San Diego and Hunter College of the City University of New York (CUNY) have identified potential human molecular targets of the anti-HIV drug Nelfinavir, which may explain why the drug is also effective as a cancer therapy. Their study will be published in the online edition of PLoS Computational Biology on April 28.
Nelfinivir is a protease inhibitor that prevents replication of the HIV virus, but it has also been found to have a positive effect on a number of solid tumor types, and is currently in clinical trial as a cancer ...
Monkeys, too, can recollect what they've seen
2011-04-29
It's one thing to recognize your childhood home when you see it in a photograph and quite another to accurately describe or draw a picture of it based on your recollection of how it looked. A new report published online on April 28 in Current Biology, a Cell Press publication, offers some of the first clear evidence that monkeys, like humans, have the capacity for both forms of memory.
The researchers found that rhesus monkeys can flexibly recall extremely simple shapes from memory, as evidenced by their ability to reproduce those shapes on a computer touch screen. The ...
Our own status affects the way our brains respond to others
2011-04-29
Our own social status influences the way our brains respond to others of higher or lower rank, according to a new study reported online on April 28 in Current Biology, a Cell Press publication. People of higher subjective socioeconomic status show greater brain activity in response to other high-ranked individuals, while those with lower status have a greater response to other low-status individuals.
These differences register in a key component of the brain's value system, a region known as the ventral striatum.
"The way we interact with and behave around other people ...
Through unique eyes, box jellyfish look out to the world above the water
2011-04-29
Box jellyfish may seem like rather simple creatures, but in fact their visual system is anything but. They've got no fewer than 24 eyes of four different kinds. Now, researchers reporting online on April 28 in Current Biology, a Cell Press publication, have evidence revealing that four of those eyes always peer up out of the water, regardless of the way the rest of the animal is oriented. What's more, it appears that those eyes allow the jellies to navigate their way around the mangrove swamps in which they live.
"It is a surprise that a jellyfish—an animal normally considered ...
Antibiotic-resistant bacteria have evolved a unique chemical mechanism, new discovery reveals
2011-04-29
For the first time, scientists have been able to paint a detailed chemical picture of how a particular strain of bacteria has evolved to become resistant to antibiotics. The research is a key step toward designing compounds to prevent infections by recently evolved, drug-resistant "superbugs" that often are found in hospitals, as well as in the general population. A paper describing the research, by a team led by Squire Booker, an associate professor in the department of chemistry and the department of biochemistry and molecular biology at Penn State University, will be ...
Long Island Pediatric Dentist Announces Grand Opening Special
2011-04-29
Come Orthodontics and Pediatric Dentistry, Long Island pediatric dentists, is pleased to announce the opening of their practice with special incentives for patients. With the opening of Come Orthodontics and Pediatric Dentistry, patients can receive a special promotion - $90 for an exam, cleaning and x-rays.
"We wanted to make the opening of our practice exciting and special for our patients. The special makes receiving dental care easy and affordable, paving way to a future of proper oral health care in our comfortable, state-of-the-art facility," said Dr. ...